Table 4 Robustness checks, results of the outcome equation (estimation of BZD overuse)
From: Work accident effect on the use of psychotropic drugs: the case of benzodiazepines
Main model | Check 1 | Check 2 | Check 3 | Check 4 | Check 5 | Check 6 | Check 7 | |
|---|---|---|---|---|---|---|---|---|
Coefficient of WA variable (SE) | 0.1099*** (0.0099) | 0.1107*** (0.0099) | 0.1176*** (0.0097) | 0.0806*** (0.018) | 0.0543 (0.0349) | 0.1011*** (0.0107) | 0.082*** (0.0114) | 0.1074*** (0.0097) |
Identification variable | Inflammatory or rare disease or HIV/AIDS | None | Sex | Inflammatory or rare disease or HIV/AIDS | Inflammatory or rare disease or HIV/AIDS | Inflammatory or rare disease or HIV/AIDS | Inflammatory or rare disease or HIV/AIDS | None |
Population | Selected population | Selected population | Selected population | Population with sickness benefits | Matched population | Selected population | Selected population | Selected population |
Overuse variable | 4 out of 5 months with BZDs | 4 out of 5 months with BZDs | 4 out of 5 months with BZDs | 4 out of 5 months with BZDs | 4 out of 5 months with BZDs | 5 out of 6 months with BZDs | 6 out of 7 months with BZDs | 4 out of 5 months with BZDs |
Health controls | 15 health-related variables | 15 health-related variables | 15 health-related variables | 15 health-related variables | 15 health-related variables | 15 health-related variables | 15 health-related variables | Decile of health expenditure |
Observations | 224,371 | 224,371 | 224,371 | 50,476 | 70,512 | 224,371 | 224,371 | 224,371 |